Data suggest that blood transfusion can cause immunosuppression. The incidence of recurrence of tumours was examined retrospectively in patients who had undergone potentially curative operations for cancer of the colon during 1970-81. Tumours recurred in six of 68 patients (9%) who had not been given transfusions and in 56 of 129 patients (43%) who had (p <0 0001). Transfusion was also found to be significantly associated with the time to
Our findings fail to show with any certainty whether viruses play a part in the pathogenesis of acute otitis media. An appreciable rise in titre to antibodies against a respiratory virus was found in 15 (25%0) of the 60 patients tested: four had received antibiotics alone and 11 myringotomy alone or in combination. Pathogenic bacteria were isolated from the middle ear in six of these 11 patients.
Complications developed in few cases. The two patients with mastoiditis, who also were identified easily, responded well to amoxycillin. Regardless of the type of treatment, the incidence of mastoiditis has decreased greatly over the past few decades; before 1946 the incidence in patients with otitis was 10-44%; in 1954 Rudberg could still report an incidence of 170'. 9 The use of antibiotics in all cases of otitis cannot be the cause of this considerable decrease; if it were the decrease would have been less pronounced in the Netherlands, where myringotomy without an antibiotic has been the common treatment. Moreover, mastoiditis would have developed in more patients during our trial. In the Netherlands antibiotics are likely to be used when otitis takes an unsatisfactory course despite myringotomy. Our patients with a severe course or with persistent discharge after 14 days may have included patients susceptible to mastoiditis in whom antibiotics prevented this complication. Thus antibiotic treatment in this selective group may have contributed to a reduction in the incidence of mastoiditis; this does not, however, explain the difference in incidence between the 1940s and the past decade. The conclusion therefore seems justified that both the decrease in the incidence of mastoiditis and the surprisingly favourable course of acute otitis media treated with nose drops and analgesics alone can be explained by changes in the clinical features of this condition.
In conclusion, treatment of acute otitis media in children can be limited to nose drops and analgesics for the first three to four days. An antibiotic, preferably a penicillin, can be given in the severe cases (still ill after three to four days with persistent high temperature or severe pain, or both) and to patients who do not clinically appear to be ill but still have discharge of the ear after two weeks. Should this treatment not lead to clinical improvement within a few days, further antibiotic treatment should be determined on the basis of a culture. Parents must be instructed to return to the general practitioner if the clinical course is unsatisfactory. If this decision cannot be left to the parents the general practitioner should make a further visit obligatory.
Introduction
Recent clinical and laboratory data obtained in animals agree with the hypothesis that homologous blood transfusion decreases immune responsiveness.' Animal and human recipients of renal transplants have a lower incidence of rejection of the graft if they have previously received blood transfusion.2 3 Growth of tumours in animals that have received transfusions may be more rapid than in those that have not. 4 Dukes's stage A; into but not through the muscularis Bl; through the muscularis B,; and with regional lymph node metastasis C1 or C2, depending on whether the colon wall was penetrated. We omitted from the study 466 patients who were operated on elsewhere (377 patients, 81%/), who were followed up for less than six months after their operation (28, 6%), who had distant metastases at the time of operation (42, 9%), or whose records of transfusions were not available.
Patients were considered to have had transfusions if they had received any blood product within one month before or after their operation. Duration of operation was defined as the time from induction of anaesthesia to surgical closure as detailed in the anaesthetist's notes. The duration of follow up was defined as the interval in days between operation and the last progress note in the medical record or the date of recurrence or death if this occurred. Patients who died of cancer of the colon within the initial six months' follow up were included in our analysis. A total of 197 patients met the criteria for entry to the study.
STATISTICAL ANALYSIS
We used X2 statistics to compare the incidence of recurrence in various groups defined by the variables that were studied. Yates's correction for continuity was applied when analysing two by two tables.7 Preliminary results suggested that recurrence was associated with receipt of blood transfusions. The extent of this association, however, was roughly the same regardless of the number of units transfused. Thus the transfusion variable was recorded into two categories-that is, transfusion given or not given. Similarly, duration of operation was regrouped into duration of less than or equal to two hours and greater than two hours. The patient's age was initially categorised into five intervals-that is, < 40, 41-50, 51-60, 61-69, and >71. Packed cell volume on admission to hospital was used to divide patients into four groups: men with packed cell volume <0-41, men with packed cell volume >041, women with packed cell volume < 0-38, and women with packed cell volume > 0-38. As our data spanned over 10 years we included in our analyses an additional binary variable, year of operation, which indicated whether a patient had the operation before or after 1975. The inclusion of this variable was to adjust for possible differences in the practice of giving blood transfusions.
Age, duration of operation, Dukes's stage, location of tumour, packed cell volume group by sex, and year of operation were included in a multivariate stepwise logistic regression analysis to identify prognostic factors that would be likely to lead to a patient having to receive a blood transfusion. Kaplan-Meier's product limit estimates for time to recurrence were computed for patients who had received transfusions and those who had not. 9 Finally, all baseline factors, other than transfusion state, were included in an analysis of time to recurrence, using a proportional hazards model.10 Non-significant factors were excluded from the model, leaving only significant ones for time to recurrence. Transfusion state was then added to the proportional hazards model obtained to see whether the change in the log likelihood after including transfusion state was significant. By entering information on transfusions last we could measure the impact of blood transfusion on recurrence after adjustment for other factors. We thus obtained an estimate of the effect on recurrence attributable to blood transfusion state.
Results
Recurrence or death due to recurrence was seen during follow up in six of 68 patients (9%) who had not received a transfusion and in 56 of 129 patients (43%) who had (p<O-0001). Estimates of the distributions of the time to recurrence were computed for patients who had received transfusions and those who had not using Kaplan-Meier's Packed cell volume on admission was known in 179 of the 197 patients and was significantly associated with transfusion. Of the 114 patients who had had a transfusion, 86 (75°o) had packed cell volumes on admission that were less than 0-41 compared with 24 of 65 (37 0) who had not had a transfusion (p < 0-005). Despite the relations between incidence of recurrence and transfusion and between transfusion and packed cell volume on admission there was no discernible association between packed cell volume on admission and incidence of recurrence.
Patients who had not received transfusions were less likely to have received chemotherapy or irradiation or both than those who had had transfusions (seven of 68 patients (100o) v 29 of 126 (23%)) (p < 0-05).
In most of these instances treatment was palliative after recurrence had occurred. (280 )). When only patients with tumours of the left colon were considered the difference in incidence of recurrence between patients who had had transfusions and those who had not was significant (p <00005) (table II). Information on the location of the tumour was unobtainable or ambiguous for 20 patients.
The incidence of recurrence was found to be significantly higher in patients whose operations lasted two hours or more (p < 0 05). When controlled for transfusion state, however, the difference in incidence of recurrence with respect to duration of operation was no longer apparent (table III) . To evaluate which factors were significantly associated with receipt of a transfusion a multivariate stepwise logistic regression, using blood transfusion as a binary response variable and age, packed cell volume group, Dukes's stage, location of tumour, year of operation, and duration of operation as predictors, was performed. Only age, location of tumour, duration of operation, and packed cell volume group were significantly associated with blood transfusion after adjustment for other factors (p < 0-05). These findings were consistent with the general notion that older people, people undergoing longer operations, and people with preoperative anaemia are more likely to receive blood transfusion. Of the three sites of tumour, tumours in the rectum were associated with the highest incidence of transfusion and in the left colon with the lowest. A proportional hazards model was fitted to time to recurrence, using all the baseline factors as covariates. Transfusion state was not included in the first set of these models. Tests based on differences in the log likelihood were used to determine whether a particular baseline factor was significant. Of the three locations of tumours, the rectum was associated with the highest risk of recurrence. The two other significant factors (at the 0 05 level) were age (< 70 or > 70) and duration of operation (.< two hours or > two hours). Generally, older people and people with operations that took longer had higher risks of recurrence. When transfusion was added to the proportional hazards model as an additional covariate the log likelihood was increased by 6- limits of 1 71 and 10-48. This result was consistent with the hypothesis that blood transfusion has a significant effect (p < 0 05) on recurrence beyond that attributable to the baseline factors.
Discussion
Our findings confirmed the results of Burrows and Tartter.6 Within the constraints and limitations imposed by our retrospective method, blood transfusion was more closely associated with recurrence of surgically resectable colorectal cancers than previously identified prognostic factors such as Dukes's stage and location of tumour.'1 Whether this association represents cause and effect is unknown. Clearly, patients who have preoperative anaemia, undergo long operations, or have rectal cancers are more likely to receive transfusions than patients with more favourable clinical circumstances. When taken individually or cumulatively, however, factors such as Dukes's stage, packed cell volume on admission to hospital, and duration of operation are insignificant predictors of recurrence after adjustment is made for transfusion state. It is possible that transfusion state is closely related to some as yet unidentified prognostic factor or factors but is not itself causally related to recurrence.
An incidental finding from the review of our patients' records was that many transfusions were given for indications that were not easily discernible. Many patients with normal preoperative packed cell volumes received one or two units of blood during or after their operation. Table IV shows the numbers of transfusions received by each patient. We do not claim that transfusion is causally related to recurrence of tumours, merely that an association exists and remains unexplained. If subsequent investigations conclude that blood transfusion has deleterious effects in patients with colorectal cancer, toleration of moderate anaemia might result in fewer patients being given transfusions.
